Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Antares Pharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.

Stock Price

$5.6

2022-05-24

Market Capitalization

$950.5 M

2022-05-24

Revenue

$184 M

FY, 2021

CreditSafe Score

?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019FY, 2020FY, 2021
Revenue16.5M22.6M20.6M26.5M45.7M52.2M54.5M63.6M123.9M149.6M184.0M
Revenue growth, %28.5%72.3%14.4%
Cost of goods sold6.8M9.5M9.2M11.2M19.5M28.8M27.5M31.1M50.5M
Gross profit9.7M13.1M11.4M15.3M26.2M23.4M27.0M32.5M73.4M
Gross profit margin, %58.7%57.8%55.4%57.6%57.4%44.8%49.6%51.1%59.2%
General and administrative expense5.8M7.2M8.3M31.7M26.9M26.4M30.4M36.8M61.8M62.8M73.9M
Operating expense total14.1M24.5M23.6M50.4M46.7M47.5M43.5M36.6M72.4M72.9M
EBIT(4.4M)(11.5M)(20.9M)(35.1M)(20.5M)(24.1M)(16.5M)(4.1M)992.0K13.6M65.9M
EBIT margin, %-27.0%-50.7%-101.1%-132.5%-44.8%-46.2%-30.2%-6.5%0.8%9.1%
Interest income55.6K63.2K111.6K76.7K60.5K79.8K
Interest expense887.0292.0K2.4M
Pre tax profit(11.4M)(24.2M)(16.7M)(6.5M)(2.0M)9.9M62.3M
Income tax expense(300.0K)25.0K175.0K100.0K(46.3M)16.0M
Net Income(4.4M)(11.4M)(20.5M)(35.2M)(20.7M)(24.3M)(16.7M)(6.5M)(2.0M)56.2M46.3M

Footer menu